Pharmaceutical Industry

The innovative Pharmaceutical industry in the United States produces chemically-derived drugs developed as a result of extensive R&D and Clinical trials in both humans and animals.  The innovator relies on patents and other forms of intellectual property rights to justify the investment required to bring a product to market (the U.S. patent term is 20 years).  Several large multinationals produce the majority of innovative pharmaceuticals globally, but they have come to rely more heavily on research performed by industry partners, including smaller, innovative manufacturers.  Pricing of innovative pharmaceuticals is designed to recapture R&D expenditures.

  • Drug Discovery
  • Pharmaceutical Packaging
  • Quality Control
  • Quality Assurance
  • GMP & cGMP
  • Quality by Design
  • Quality Risk Assessment

Related Conference of Pharmaceutical Industry

September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 14-15, 2026

5th Global Summit on Pharmaceutical Research

Paris, France
January 26-27, 2027

22nd Annual Meet on Pharmaceutical Sciences

Paris, France
February 15-16, 2027

23rd Annual Congress on Pharmacology and Toxicology

Paris, France
April 08-09, 2027

21st World Drug Delivery Summit

Vienna, Austria
April 27-28, 2027

10th European Biopharma Congress

Paris, France
April 27-28, 2027

19th World Drug Delivery Summit

Paris, France

Pharmaceutical Industry Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in